A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for ​betting on the ...

Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

But deciding if it's a good buy takes a little more looking.

They could perhaps see sustained runs beyond this year.

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

A life sciences hub in Syracuse is getting a major upgrade as New York pushes to grow its biotechnology sector. Gov. Kathy ...

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

Genentech, a biotechnology company that pledged last year to build a manufacturing facility in southern Wake County, said it ...

DermCeutical EDLTM is a topical bioactive ingredient that Debut claims delivers skin-tightening benefits.

Department of Economic & Community Development Commissioner Daniel O'Keefe speaks at the BioCT legislative breakfast in New ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...